Etienne Meylan
Assistant Professor
School of Life Science
Swiss Institute for Experimental Cancer Research
Switzerland
Biography
Etienne Meylan received a PhD in Life Sciences from the University of Lausanne in 2006, for his work on innate immunity performed in the laboratory of Jürg Tschopp. From 2007 to 2010, he worked as a postdoctoral fellow in the laboratory of Tyler Jacks, at the Koch Institute for Integrative Cancer Research, MIT, Cambridge USA. In 2011, he established his research laboratory at ISREC, as a Swiss National Science Foundation Professor and Tenure-track Assistant Professor. His laboratory focuses on the molecular mechanisms that contribute to the development of non-small cell lung cancer.
Research Interest
To study how the signaling pathways that are known to regulate innate immunity or glucose metabolism contribute to the development of non-small cell lung cancer (NSCLC); Non-small cell lung cancer; Glucose transporters; Glucose metabolism in cancer; Innate immunity; Mouse models of cancer
Publications
-
Meylan E, Dooley AL, Feldser DM, Shen L, Turk E, Ouyang C, Jacks T. (2009) Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. Nature 462: 104-7.
-
Xue W, Meylan E, Oliver TG, Feldser DM, Winslow MM, et al. (2011) Response and resistance to NF-κB inhibitors in mouse models of lung adenocarcinoma. Cancer Discov 1: 236-247.
-
Peters S, Meylan E. (2013) Targeting receptor activator of nuclear factor-kappa B as a new therapy for bone metastasis in non-small cell lung cancer. Current Opinion in Oncology 25: 137-144.
